Search clinical trials for: high risk for developing cancer

Total 379567 results

Memorial Sloan Kettering Cancer Center

Recruiting

A Study of Early Cancer Detection in People at High Risk of Developing Pancreatic Ductal Adenocarcinoma (PDAC)

Pancreatic Cyst

United States
Regeneron Pharmaceuticals

Recruiting

A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma

Smoldering Multiple Myeloma (SMM)

Spain
University of Chicago

Recruiting

MRI Screening in Men at High Risk of Developing Prostate Cancer

Prostate Cancer Screening

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Stand Up To Cancer

Recruiting

Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer

Pancreatic Cancer | High Risk Cancer

United States
Dana-Farber Cancer Institute
Stand Up To Cancer

Recruiting

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)

Multiple Myeloma

United States
Carol Fabian, MD

Recruiting

Protocol for Women at Increased Risk of Developing Breast Cancer

Breast Cancer

United States
Bayer

Active, not recruiting

A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer (OASIS-4)

Hot Flashes | Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer

Spain, France, Belgium, United Kingdom, Hungary, Israel, Italy, Ireland, Germany, Portugal, Finland, Poland, Romania, Canada, Austria, Kazakhstan
M.D. Anderson Cancer Center

Active, not recruiting

Prophylactic Salpingectomy With Delayed Oophorectomy

Ovarian Carcinoma

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer

High Risk for Developing Breast Cancer

United States
Boston University
American College of Radiology Imaging Network

Active, not recruiting

DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer (DECAMP-2)

Pulmonary Disease

United States
Hoffmann-La Roche

Terminated

A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy (IMmotion010)

Renal Cell Carcinoma

Korea, Republic of, United States, Canada, United Kingdom, Argentina, Australia, Belgium, Brazil, China, Denmark, Ireland, Spain, Japan, Netherlands, Chile, Czechia, Italy, France, Israel, Turkey, Germany, Austria, Taiwan, Serbia, Poland, Thailan... and more
Carol Fabian, MD
Johns Hopkins University; National Cancer Institute (NCI); University of Alabama... and other collaborators

Completed

Protocol to Examine Methylation of Tumor Suppression Genes in Women at High Risk of Developing Breast Cancer

Breast Cancer
Atara Biotherapeutics
National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center

Completed

Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies

EBV-induced Lymphomas | EBV-associated Malignancies | Transplant Patients With EBV Viremia at High Risk of Developing a Recurrent EBV Lymphoma

United States
Atara Biotherapeutics
Memorial Sloan Kettering Cancer Center

Completed

Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies

EBV-induced Lymphomas | EBV-associated Malignancies | Transplant Patients With EBV Viremia at High Risk for Developing a Recurrent EBV Lymphoma

United States
Zhejiang University

Completed

Surgery With HIPEC in Treating Patients With a High Risk of Developing Colorectal Peritoneal Carcinomatosis

Peritoneal Carcinomatosis | Malignant Neoplasm of Large Intestine TNM Staging Primary Tumor (T) T4

China
National Jewish Health

Completed

Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker

High Risk of Developing Lung Cancer

United States
Abramson Cancer Center of the University of Pennsylvania
National Cancer Institute (NCI)

Completed

Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer

Breast Cancer | Healthy, no Evidence of Disease

United States
Carol Fabian, MD
Intergenetics, Inc.

Withdrawn

Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer

Breast Cancer

United States
Abramson Cancer Center of the University of Pennsylvania
National Cancer Institute (NCI)

Completed

MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer

Breast Cancer

United States, Canada
Ohio State University Comprehensive Cancer Center

Completed

Dietary Fish and Omega 3 Fatty Acids for Breast Cancer Prevention

Breast Cancer

United States
Mayo Clinic

Completed

Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer

Breast Cancer

United States
Thomas E. Ahlering
National Cancer Institute (NCI)

Completed

Eflornithine in Treating Patients At High Risk of Developing Prostate Cancer

Prostate Cancer

United States
Pathway Genomics

Completed

Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease (H1000)

Neoplasms | Mutation

United States
National Cancer Centre, Singapore

Unknown

Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases

Colorectal Cancer | Peritoneal Metastases

Singapore
Wake Forest University
Johns Hopkins University; Memorial Sloan Kettering Cancer Center; Mayo Clinic; University... and other collaborators

Completed

Do Your Genes Put You at a Higher Risk of Developing Mesothelioma

Mesothelioma

United States
University of Texas Southwestern Medical Center
The University of Texas Health Science Center, Houston; Johns Hopkins Bloomberg... and other collaborators

Completed

RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System

Carcinoma, Hepatocellular | Liver Neoplasms

United States
Vanderbilt University Medical Center
National Cancer Institute (NCI)

Completed

Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer Syndromes or Who Are at High Risk of Developing Colorectal Cancer

Colorectal Cancer | Precancerous Condition | Hereditary Non-polyposis Colon Cancer

United States
National Cancer Institute (NCI)

Withdrawn

Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases

Peritoneal Carcinomatosis | Colorectal Carcinoma

United States
Vanderbilt University
National Cancer Institute (NCI)

Completed

Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer

Gastric Cancer | Precancerous Condition

United States
Carol Fabian, MD
Susan G. Komen Breast Cancer Foundation

Completed

Protocol for Women at Increased Risk of Developing Breast Cancer

Breast Cancer

United States
Carol Fabian, MD
Novartis

Completed

Protocol for Women at Increased Risk of Developing Breast Cancer

Breast Cancer

United States
Roswell Park Cancer Institute

Terminated

Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer

Breast Cancer | Precancerous Condition

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants

Prostate Cancer | Precancerous Condition

United States
Swedish Medical Center
Fred Hutchinson Cancer Center; The Marsha Rivkin Center for Ovarian Cancer...

Terminated

Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer (OCEDP)

Ovarian Diseases | Ovarian Neoplasms

United States
Northwestern University

Terminated

Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer

United States
Medical College and Hospital Kolkata

Completed

Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast Cancer

Benign Breast Disease | Mastalgia | Fibroadenoma | Fibrocystic Disease of Breast

India
Royal Marsden NHS Foundation Trust

Completed

Nipple Aspiration, Ductal Lavage, and Duct Endoscopy in Screening Women at Moderate-to-High Risk of Developing Breast Cancer

Breast Cancer

United Kingdom
Cedars-Sinai Medical Center

Unknown

Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer

Breast Cancer

United States
South West Wales Cancer Institute

Unknown

Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers

Tobacco Use Disorder | Lung Cancer

United Kingdom
University of Illinois at Chicago
National Cancer Institute (NCI)

Completed

Lycopene in Preventing Prostate Cancer in Patients Who Are at High Risk of Developing Prostate Cancer

Prostate Cancer
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Natural History of Lung Nodules Seen on CT Scans From Participants at High-Risk of Developing Lung Cancer

Lung Cancer | Precancerous Condition

Italy
Northwestern University
National Cancer Institute (NCI)

Withdrawn

Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy

Breast Cancer

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Developing Interview Questions to Estimate Workplace Exposure to Electric and Magnetic Fields

Brain and Central Nervous System Tumors

United States
Carol Fabian, MD

Completed

Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer

Breast Cancer

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Stanford University
United States Department of Defense; National Institutes of Health (NIH)

Completed

Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer

Breast Cancer

United States
Massachusetts General Hospital

Completed

Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer

Breast Cancer | Hot Flashes | Sleep Disorders

United States
University of Arizona
National Cancer Institute (NCI)

Completed

Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries

Ovarian Cancer | brca1 Mutation Carrier | brca2 Mutation Carrier

United States
Jewish Hospital and St. Mary's Healthcare

Unknown

Chest X-Ray or Chest CT Scan in Patients at High Risk of Developing Lung Cancer

Lung Cancer

United States
National Cancer Institute (NCI)

Completed

A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer

Breast Cancer | Breast Neoplasms

United States

Search clinical trials for: high risk for developing cancer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations